MD

Manoharan Desamuthu

Director Director DIN 02525997
DIN 02525997 First appointment Nov 2001 Primary industry General Business
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 0 active board seats
Past companies 1 historical roles
Total affiliations 1 Since Nov 2001
Shareholding value Locked Premium profile

About Manoharan Desamuthu

Data last updated:

Manoharan Desamuthu has 24 years in corporate governance. Formerly with 1 company, such as Apharmo Limited. Engaged in General Business. Contributes to corporate operations.

DIN 02525997
Primary Designation Director
First Appointment 26 Nov 2001
Oldest Company Age Not Provided

Current companies

No current companies available.

Previous companies

CompanyDesignationAppointmentFoundedStatus
Apharmo Limited U24231TN1993PLC025375
Director26 Nov 20011993Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Apharmo Limited
Premium access

Shareholding and investment profile for Manoharan Desamuthu

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Manoharan Desamuthu

Manoharan Desamuthu has 24 years in corporate governance. Formerly with 1 company, such as Apharmo Limited. Engaged in General Business. Contributes to corporate operations.

Manoharan Desamuthu is associated with 0 companies as a director.

Manoharan Desamuthu has expertise in General Business.

Manoharan Desamuthu has 24 years in corporate governance.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available